75% Overall Response from Moxetumomab 41% of patients had complete response - 102337

Spotlight
Video

75% Overall Response from Moxetumomab 41% of patients had complete response

Loading........
Description: Michelle Dawson, MD, AstraZeneca, talks about 75% Overall Response from Moxetumomab 41% of patients had complete response at Annual Meeting 2018.
Shared By : Annual-Meeting
Posted on : 06/06/18
Added : 12 months ago



Recommended

Nothing found.